Crossref
GEFITINIB IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): ANALYSIS OF EFFICACY
Research in Oncology · 2009
DOI: 10.21608/resoncol.2009.402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Oncology, 2009. Verfasst von Mahmoud Abdelsalam.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdelsalam, M. (2009). GEFITINIB IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): ANALYSIS OF EFFICACY. Research in Oncology. https://doi.org/10.21608/resoncol.2009.402
Vancouver
Abdelsalam M. GEFITINIB IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): ANALYSIS OF EFFICACY. Research in Oncology. 2009. doi:10.21608/resoncol.2009.402
BibTeX
@article{Abdelsalam2009,
author = {Abdelsalam, Mahmoud},
title = {GEFITINIB IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): ANALYSIS OF EFFICACY},
journal = {Research in Oncology},
year = {2009},
doi = {10.21608/resoncol.2009.402}
}
EUVIMED